<?xml version="1.0" encoding="UTF-8"?>
<p>Beyond US foreign relations, there are opportunities for vaccines to promote cooperation between Asian nations. For instance, each of the largest Asian countries, i.e., China, India, Indonesia, Japan, and Vietnam, has capabilities to develop and produce new vaccines 
 <xref rid="pntd.0002808-Hotez12" ref-type="bibr">[56]</xref>, 
 <xref rid="pntd.0002808-Hotez17" ref-type="bibr">[61]</xref>. China and India engaged in overt hostilities in 1964, while China's recent territorial claims in the East China Sea have sparked fresh tensions in the region 
 <xref rid="pntd.0002808-Hotez17" ref-type="bibr">[61]</xref>. Both Sabin and another PDP, the International Vaccine Institute (IVI) based in Seoul, Korea 
 <xref rid="pntd.0002808-International1" ref-type="bibr">[62]</xref>, could help mediate vaccine diplomacy between these nations. In addition, Brazil, which also has major vaccine capabilities, has initiated South-South partnerships with Lusophone Africa and could become an important actor in vaccine diplomacy 
 <xref rid="pntd.0002808-Almedia1" ref-type="bibr">[63]</xref>. Vaccine manufacturing organizations associated with many of the key OIC and Asian nations targeted for vaccine science diplomacy belong to the unique Developing Countries Vaccine Manufacturers Network (DCVMN) 
 <xref rid="pntd.0002808-DCVMN1" ref-type="bibr">[64]</xref>. Both the GAVI Alliance and WHO could have key roles in coordinating these activities. These organizations also have a key role in a new Sustainable Immunization Financing program inaugurated with Gates Foundation support by Dr. Ciro De Quadros at the Sabin Vaccine Institute, which focuses on 12 African countries, five Asian countries, and one Central Asian country 
 <xref rid="pntd.0002808-Sabin1" ref-type="bibr">[65]</xref>.
</p>
